HEADER IMMUNE SYSTEM 01-AUG-01 1JP5 TITLE CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH TITLE 2 THE EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-1 PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SINGLE-CHAIN FV FRAGMENT 1696; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: SCFV1696; COMPND 5 SYNONYM: IGG1/KAPPA ANTIBODY; IMMUNOGLOBULIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: EPITOPE PEPTIDE CORRESPONDING TO N-TERMINUS OF HIV-1 COMPND 9 PROTEASE; COMPND 10 CHAIN: C, D; COMPND 11 ENGINEERED: YES; COMPND 12 OTHER_DETAILS: NONAPEPTIDE PQITLWQRR SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: OCTAMER PQITLWQR FROM THE N-TERMINUS OF HIV-1 SOURCE 12 PROTEASE, R ADDED TO THE C-TERMINUS TO INCREASE SOLUBILITY KEYWDS ANTIBODY-ANTIGEN COMPLEX, HIV PR INHIBITING ANTIBODY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR P.REZACOVA,J.LESCAR,J.BRYNDA,M.FABRY,M.HOREJSI,J.SEDLACEK,G.A.BENTLEY REVDAT 4 13-NOV-24 1JP5 1 REMARK REVDAT 3 16-AUG-23 1JP5 1 REMARK REVDAT 2 24-FEB-09 1JP5 1 VERSN REVDAT 1 12-OCT-01 1JP5 0 JRNL AUTH P.REZACOVA,J.LESCAR,J.BRYNDA,M.FABRY,M.HOREJSI,J.SEDLACEK, JRNL AUTH 2 G.A.BENTLEY JRNL TITL STRUCTURAL BASIS OF HIV-1 AND HIV-2 PROTEASE INHIBITION BY A JRNL TITL 2 MONOCLONAL ANTIBODY. JRNL REF STRUCTURE V. 9 887 2001 JRNL REFN ISSN 0969-2126 JRNL PMID 11591344 JRNL DOI 10.1016/S0969-2126(01)00654-2 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 897041.430 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 12488 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1286 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1785 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 11.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 225 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3764 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 42.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.12000 REMARK 3 B22 (A**2) : -5.29000 REMARK 3 B33 (A**2) : 2.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.18000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.42 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.47 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.57 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.180 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.040 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.610 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.560 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 16.69 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JP5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-AUG-01. REMARK 100 THE DEPOSITION ID IS D_1000014023. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAY-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9340 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED GE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12620 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : 0.09700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: VARIABLE DOMAINS OF FAB 1696 (PDB CODE 1CL7) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M TRI-SODIUM CITRATE, 0.1M SODIUM REMARK 280 PHOSPHATE, 24% PEG 3400, 0.2M AMMONIUM SULPHATE, PH 5.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP AT 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.53000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 113 REMARK 465 GLY A 114 REMARK 465 GLY A 115 REMARK 465 GLY A 116 REMARK 465 SER A 117 REMARK 465 GLY A 118 REMARK 465 GLY A 119 REMARK 465 GLY A 120 REMARK 465 GLY A 121 REMARK 465 SER A 122 REMARK 465 GLY A 123 REMARK 465 GLY A 124 REMARK 465 GLY A 125 REMARK 465 GLY A 126 REMARK 465 SER A 127 REMARK 465 GLY B 113 REMARK 465 GLY B 114 REMARK 465 GLY B 115 REMARK 465 GLY B 116 REMARK 465 SER B 117 REMARK 465 GLY B 118 REMARK 465 GLY B 119 REMARK 465 GLY B 120 REMARK 465 GLY B 121 REMARK 465 SER B 122 REMARK 465 GLY B 123 REMARK 465 GLY B 124 REMARK 465 GLY B 125 REMARK 465 GLY B 126 REMARK 465 SER B 127 REMARK 465 GLN C 7 REMARK 465 ARG C 8 REMARK 465 ARG C 9 REMARK 465 GLN D 7 REMARK 465 ARG D 8 REMARK 465 ARG D 9 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS B 23 CA - CB - SG ANGL. DEV. = 7.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 56 -62.36 63.39 REMARK 500 ASP A 65 3.13 -67.03 REMARK 500 SER A 72 147.41 -178.20 REMARK 500 LYS A 192 -77.95 -52.69 REMARK 500 ARG A 227 47.65 -151.04 REMARK 500 PHE A 234 66.86 64.55 REMARK 500 VAL B 56 -66.71 65.89 REMARK 500 SER B 72 149.37 -178.62 REMARK 500 ALA B 155 98.18 -64.54 REMARK 500 LYS B 192 -76.86 -51.27 REMARK 500 ARG B 227 43.80 -146.79 REMARK 500 PHE B 234 64.47 67.65 REMARK 500 THR C 4 -95.68 -111.62 REMARK 500 LEU C 5 -81.94 33.94 REMARK 500 LEU D 5 171.45 64.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CL7 RELATED DB: PDB REMARK 900 ANTI HIV1 PROTEASE FAB REMARK 900 RELATED ID: 2HRP RELATED DB: PDB REMARK 900 ANTIGEN-ANTIBODY COMPLEX REMARK 900 RELATED ID: 1MF2 RELATED DB: PDB REMARK 900 ANTI HIV1 PROTEASE FAB COMPLEX DBREF 1JP5 A 1 247 PDB 1JP5 1JP5 1 247 DBREF 1JP5 B 1 247 PDB 1JP5 1JP5 1 247 DBREF 1JP5 C 1 9 PDB 1JP5 1JP5 1 9 DBREF 1JP5 D 1 9 PDB 1JP5 1JP5 1 9 SEQRES 1 A 247 ASP ILE LEU MET THR GLN THR PRO LEU TYR LEU PRO VAL SEQRES 2 A 247 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 A 247 GLN THR ILE VAL HIS ASN ASN GLY ASN THR TYR LEU GLU SEQRES 4 A 247 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 A 247 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 A 247 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 A 247 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY ILE TYR SEQRES 8 A 247 TYR CYS PHE GLN GLY SER HIS PHE PRO PRO THR PHE GLY SEQRES 9 A 247 GLY GLY THR LYS LEU GLU ILE LYS GLY GLY GLY GLY SER SEQRES 10 A 247 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLU VAL GLN SEQRES 11 A 247 LEU GLN GLN SER GLY PRO GLU LEU LYS LYS PRO GLY GLU SEQRES 12 A 247 THR VAL LYS ILE SER CYS LYS ALA THR ASN TYR ALA PHE SEQRES 13 A 247 THR ASP TYR SER MET HIS TRP VAL LYS GLN ALA PRO GLY SEQRES 14 A 247 GLY ASP LEU LYS TYR VAL GLY TRP ILE ASN THR GLU THR SEQRES 15 A 247 ASP GLU PRO THR PHE ALA ASP ASP PHE LYS GLY ARG PHE SEQRES 16 A 247 ALA PHE SER LEU ASP THR SER THR SER THR ALA PHE LEU SEQRES 17 A 247 GLN ILE ASN ASN LEU LYS ASN GLU ASP THR ALA THR TYR SEQRES 18 A 247 PHE CYS VAL ARG ASP ARG HIS ASP TYR GLY GLU ILE PHE SEQRES 19 A 247 THR TYR TRP GLY GLN GLY THR THR VAL THR VAL SER SER SEQRES 1 B 247 ASP ILE LEU MET THR GLN THR PRO LEU TYR LEU PRO VAL SEQRES 2 B 247 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 B 247 GLN THR ILE VAL HIS ASN ASN GLY ASN THR TYR LEU GLU SEQRES 4 B 247 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 B 247 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 B 247 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 B 247 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY ILE TYR SEQRES 8 B 247 TYR CYS PHE GLN GLY SER HIS PHE PRO PRO THR PHE GLY SEQRES 9 B 247 GLY GLY THR LYS LEU GLU ILE LYS GLY GLY GLY GLY SER SEQRES 10 B 247 GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLU VAL GLN SEQRES 11 B 247 LEU GLN GLN SER GLY PRO GLU LEU LYS LYS PRO GLY GLU SEQRES 12 B 247 THR VAL LYS ILE SER CYS LYS ALA THR ASN TYR ALA PHE SEQRES 13 B 247 THR ASP TYR SER MET HIS TRP VAL LYS GLN ALA PRO GLY SEQRES 14 B 247 GLY ASP LEU LYS TYR VAL GLY TRP ILE ASN THR GLU THR SEQRES 15 B 247 ASP GLU PRO THR PHE ALA ASP ASP PHE LYS GLY ARG PHE SEQRES 16 B 247 ALA PHE SER LEU ASP THR SER THR SER THR ALA PHE LEU SEQRES 17 B 247 GLN ILE ASN ASN LEU LYS ASN GLU ASP THR ALA THR TYR SEQRES 18 B 247 PHE CYS VAL ARG ASP ARG HIS ASP TYR GLY GLU ILE PHE SEQRES 19 B 247 THR TYR TRP GLY GLN GLY THR THR VAL THR VAL SER SER SEQRES 1 C 9 PRO GLN ILE THR LEU TRP GLN ARG ARG SEQRES 1 D 9 PRO GLN ILE THR LEU TRP GLN ARG ARG FORMUL 5 HOH *53(H2 O) HELIX 1 1 GLU A 84 LEU A 88 5 5 HELIX 2 2 ASP A 189 LYS A 192 5 4 HELIX 3 3 LYS A 214 THR A 218 5 5 HELIX 4 4 HIS A 228 GLY A 231 5 4 HELIX 5 5 GLU B 84 LEU B 88 5 5 HELIX 6 6 ASP B 189 LYS B 192 5 4 HELIX 7 7 LYS B 214 THR B 218 5 5 HELIX 8 8 HIS B 228 GLY B 231 5 4 SHEET 1 A 4 MET A 4 THR A 7 0 SHEET 2 A 4 ALA A 19 SER A 25 -1 N SER A 22 O THR A 7 SHEET 3 A 4 ASP A 75 ILE A 80 -1 N PHE A 76 O CYS A 23 SHEET 4 A 4 PHE A 67 SER A 72 -1 O SER A 68 N LYS A 79 SHEET 1 B 5 ASN A 58 ARG A 59 0 SHEET 2 B 5 GLN A 50 TYR A 54 -1 N TYR A 54 O ASN A 58 SHEET 3 B 5 LEU A 38 GLN A 43 -1 O TRP A 40 N LEU A 52 SHEET 4 B 5 GLY A 89 GLN A 95 -1 O ILE A 90 N GLN A 43 SHEET 5 B 5 THR A 102 PHE A 103 -1 O THR A 102 N GLN A 95 SHEET 1 C 6 ASN A 58 ARG A 59 0 SHEET 2 C 6 GLN A 50 TYR A 54 -1 N TYR A 54 O ASN A 58 SHEET 3 C 6 LEU A 38 GLN A 43 -1 O TRP A 40 N LEU A 52 SHEET 4 C 6 GLY A 89 GLN A 95 -1 O ILE A 90 N GLN A 43 SHEET 5 C 6 THR A 107 ILE A 111 -1 O THR A 107 N TYR A 91 SHEET 6 C 6 TYR A 10 VAL A 13 1 O LEU A 11 N GLU A 110 SHEET 1 D 4 GLN A 130 GLN A 133 0 SHEET 2 D 4 VAL A 145 THR A 152 -1 N LYS A 150 O GLN A 132 SHEET 3 D 4 THR A 205 ILE A 210 -1 N ALA A 206 O CYS A 149 SHEET 4 D 4 PHE A 195 ASP A 200 -1 O ALA A 196 N GLN A 209 SHEET 1 E 5 GLU A 232 TRP A 237 0 SHEET 2 E 5 ALA A 219 ARG A 227 -1 N ARG A 225 O TYR A 236 SHEET 3 E 5 MET A 161 GLN A 166 -1 N HIS A 162 O VAL A 224 SHEET 4 E 5 LEU A 172 ILE A 178 -1 O LYS A 173 N LYS A 165 SHEET 5 E 5 PRO A 185 PHE A 187 -1 N THR A 186 O TRP A 177 SHEET 1 F 4 GLU A 232 TRP A 237 0 SHEET 2 F 4 ALA A 219 ARG A 227 -1 N ARG A 225 O TYR A 236 SHEET 3 F 4 THR A 241 VAL A 245 -1 O THR A 241 N TYR A 221 SHEET 4 F 4 GLU A 137 LYS A 139 1 O GLU A 137 N THR A 244 SHEET 1 G 4 MET B 4 THR B 7 0 SHEET 2 G 4 ALA B 19 SER B 25 -1 O SER B 22 N THR B 7 SHEET 3 G 4 ASP B 75 ILE B 80 -1 N PHE B 76 O CYS B 23 SHEET 4 G 4 PHE B 67 SER B 72 -1 O SER B 68 N LYS B 79 SHEET 1 H 5 ASN B 58 ARG B 59 0 SHEET 2 H 5 PRO B 49 TYR B 54 -1 N TYR B 54 O ASN B 58 SHEET 3 H 5 LEU B 38 GLN B 43 -1 O TRP B 40 N LEU B 52 SHEET 4 H 5 GLY B 89 GLN B 95 -1 N ILE B 90 O GLN B 43 SHEET 5 H 5 THR B 102 PHE B 103 -1 O THR B 102 N GLN B 95 SHEET 1 I 6 ASN B 58 ARG B 59 0 SHEET 2 I 6 PRO B 49 TYR B 54 -1 N TYR B 54 O ASN B 58 SHEET 3 I 6 LEU B 38 GLN B 43 -1 O TRP B 40 N LEU B 52 SHEET 4 I 6 GLY B 89 GLN B 95 -1 N ILE B 90 O GLN B 43 SHEET 5 I 6 THR B 107 ILE B 111 -1 O THR B 107 N TYR B 91 SHEET 6 I 6 TYR B 10 VAL B 13 1 O LEU B 11 N GLU B 110 SHEET 1 J 4 GLN B 130 GLN B 133 0 SHEET 2 J 4 VAL B 145 THR B 152 -1 N LYS B 150 O GLN B 132 SHEET 3 J 4 THR B 205 ILE B 210 -1 N ALA B 206 O CYS B 149 SHEET 4 J 4 PHE B 195 ASP B 200 -1 O ALA B 196 N GLN B 209 SHEET 1 K 5 GLU B 232 TRP B 237 0 SHEET 2 K 5 ALA B 219 ARG B 227 -1 N ARG B 225 O TYR B 236 SHEET 3 K 5 MET B 161 GLN B 166 -1 N HIS B 162 O VAL B 224 SHEET 4 K 5 LEU B 172 ILE B 178 -1 O LYS B 173 N LYS B 165 SHEET 5 K 5 PRO B 185 PHE B 187 -1 N THR B 186 O TRP B 177 SHEET 1 L 4 GLU B 232 TRP B 237 0 SHEET 2 L 4 ALA B 219 ARG B 227 -1 N ARG B 225 O TYR B 236 SHEET 3 L 4 THR B 241 VAL B 245 -1 O THR B 241 N TYR B 221 SHEET 4 L 4 GLU B 137 LYS B 139 1 O GLU B 137 N THR B 244 SSBOND 1 CYS A 23 CYS A 93 1555 1555 2.04 SSBOND 2 CYS A 149 CYS A 223 1555 1555 2.03 SSBOND 3 CYS B 23 CYS B 93 1555 1555 2.04 SSBOND 4 CYS B 149 CYS B 223 1555 1555 2.04 CISPEP 1 THR A 7 PRO A 8 0 -0.02 CISPEP 2 PHE A 99 PRO A 100 0 -0.06 CISPEP 3 THR B 7 PRO B 8 0 0.16 CISPEP 4 PHE B 99 PRO B 100 0 -0.09 CRYST1 45.490 57.060 91.040 90.00 97.07 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021983 0.000000 0.002726 0.00000 SCALE2 0.000000 0.017525 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011068 0.00000